Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled date : 2021 - 07 - 29 save search
Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.24%
H: 0.58%
C: -1.74%
disease alzheimer alzheimer’s alzheimer's disease alzheimer's designation
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -1.17%
ARWR | $22.62 0.4% 0.4% 1.3M
|
Health Technology
|
| O: 1.95%
H: 1.82%
C: -1.98%
disease liver disease treatment fda therapy breakthrough therapy liver designation
Crohn's Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30
Published: 2021-07-29 (Crawled : 18:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.4%
H: 0.3%
C: -0.88%
GLPG | $28.9 -1.1% -1.11% 140K
|
Health Technology
|
| O: 1.31%
H: 0.45%
C: -2.15%
disease growth
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.49%
H: 0.26%
C: -0.62%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.69%
H: 0.08%
C: -0.33%
disease therapy molecular growth research merge
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease
Published: 2021-07-29 (Crawled : 14:00) - globenewswire.com
SAVA | $21.18 -0.42% -0.42% 970K
|
Health Technology
|
| O: 7.17%
H: 0.8%
C: -28.72%
disease alzheimer positive alzheimer’s alzheimer's disease alzheimer's
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease
Published: 2021-07-29 (Crawled : 14:00) - globenewswire.com
SAVA | $21.18 -0.42% -0.42% 970K
|
Health Technology
|
| O: 7.17%
H: 0.8%
C: -28.72%
disease alzheimer positive alzheimer’s alzheimer's disease alzheimer's biomarkers
AC Immune Presents Full Phase 1b Results on Anti-Abeta Vaccine and Discusses its First-in-Class Diagnostic for Parkinson’s Disease at AAIC 2021
Published: 2021-07-29 (Crawled : 12:00) - globenewswire.com
ACIU | $2.43 0.41% 0.41% 370K
|
Health Technology
|
| O: 2.04%
H: 1.06%
C: -5.45%
disease phase 1 results parkinson vaccine phase 1b diagnostic phase 2b
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
Published: 2021-07-29 (Crawled : 11:00) - prnewswire.com
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.27%
H: 0.21%
C: -0.6%
disease fda cancer breast cancer designation rare
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Significantly Prevented Aβ (Abeta)-induced Cognitive Deficits with Confirmed Significant Biomarker-response in Animal Model of Alzheimer’s Disease
Published: 2021-07-29 (Crawled : 11:00) - anavex.com
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 2.67%
H: 0.27%
C: -16.6%
disease alzheimer life science anavex®2-73 anavex alzheimer’s alzheimer's disease alzheimer's biomarkers
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.